谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Biomarker-Directed Phase II Platform Study in Patients with EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD)

Helena A. Yu,Sarah B. Goldberg,Xiuning Le,Zofia Piotrowska,Jonathan W. Goldman,Adrianus J. De Langen,Isamu Okamoto,Byoung Chul Cho,Paul Smith,Ilhem Mensi,Helen Ambrose, Silvija Kraljevic,Julie Maidment,Juliann Chmielecki,Xiaocheng Li-Sucholeiki, Gail Doughton,Gargi Patel, Phil Jewsbury, Phil Szekeres,Jonathan W. Riess

Clinical Lung Cancer（2021）

引用 39|浏览6
关键词
Acquired resistance,EGFRm,EGFR-TKI,NSCLC,post-progression
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要